Center Book Partners LP Insmed Inc Transaction History

Center Book Partners LP

  • $1.7 Billion
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
BUY
$65.25 - $83.83 $430,650 - $553,278
6,600 Added 70.28%
15,991 $1.22 Million
Q4 2024

Feb 13, 2025
SELL
$66.29 - $76.63 $4.77 Million - $5.51 Million
-71,945 Reduced 88.45%
9,391 $648,000
Q3 2024

Nov 14, 2024
BUY
$62.0 - $79.01 $5.04 Million - $6.43 Million
81,336 New
81,336 $5.94 Million

Others Institutions Holding INSM

# of Institutions
582
Shares Held
203M
Call Options Held
2.84M
Put Options Held
3.26M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $22.1B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Center Book Partners LP Portfolio

Follow Center Book Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center Book Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Center Book Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email